Myeloma is a malignancy of the plasma cells derived from the B lymphocyte series. It is characterized by early and wide dissemination of tumour cells resulting in bone destruction, anaemia, infections, hypercalcaemia, renal failure and occasionally symptoms of hyperviscosity. The myeloma cells may either produce local destruction of bone or produce paraprotein ('M' band in the serum), or the light chain moiety of the paraprotein which is excreted in the urine as Bence Jones protein. The It has been disappointing that the intense effort devoted to multidrug combinations has been so unrewarding, and that biological response modifiers such as interferon have failed to live up to their promise. The next few years should see an answer to the question whether high-dose drug therapy has anything to offer patients with myeloma.
